Testing the Epley Maneuver for Treating Dizziness in the Emergency Department
NCT07111000 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118
Last updated 2026-05-11
Summary
The goal of this randomized controlled trial is to evaluate the efficacy of the Epley maneuver versus a sham maneuver in treating patients presenting to the emergency department (ED) with BPPV. The main questions that the study aims to answer are:
* What is the mean difference in Dizziness Handicap Inventory (DHI) scores between patients receiving the Epley maneuver and those receiving the sham maneuver 3 days after enrollment?
* What is the immediate response (using a 0-10-point Likert scale) of patients in each arm of the study?
* What is the proportion of patients who, despite agreeing to participate, were unable to complete the full Epley maneuver due to symptom severity?
Researchers will compare the Epley maneuver arm to the sham maneuver arm to see if the Epley maneuver is more effective in reducing BPPV symptoms.
Participants will:
* Undergo either the Epley maneuver or a sham maneuver.
* Complete the Dizziness Handicap Inventory (DHI) questionnaire at baseline and 3 days post-discharge.
* Patients with insufficient improvement in the sham maneuver group will receive a rescue Epley maneuver.
* Have their vertigo severity assessed using a 0-10 point Likert scale at baseline, immediately and post-maneuver.
Conditions
- Benign Paroxysmal Positional Vertigo (BPPV)
Interventions
- PROCEDURE
-
Epley Maneuver
The patient's head is turned 45 degrees towards the side that caused the most nystagmus or reproduced their initial symptoms. The patient is then laid down with their head hanging over the edge of the bed. After that, the head will be rotated 90 degrees in the opposite direction, with the head remaining in a dependent position. The patient is then asked to roll onto their side with their head facing downward. They are then brought back to a sitting position and the head is moved forward 45 degrees. Each position is held until the vertigo and/or nystagmus subsides or for at least 30 seconds
- PROCEDURE
-
Sham maneuver
This control maneuver will involve coordinated movements of the hands and legs, while excluding any head movement. Patients will be at first in a sitting position with both feet on the ground and both hands placed on the thighs and then they will be asked to lift both hands off the thighs, keeping the arms extended. They will then be asked to return to their initial upright sitting position. Patients will then raise their right foot off the ground while keeping the left one planted on the ground. It will be an alternating movement between lifting the right and left feet while maintaining a smooth and well- controlled rhythm for 90 seconds.
Sponsors & Collaborators
-
American University of Beirut Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2026-07-22
- Completion
- 2026-08-22
Countries
- Lebanon
Study Locations
More Related Trials
-
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
NCT04272255 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
NCT03988530 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
NCT03908567 ·Status: COMPLETED ·Phase: PHASE2
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo
NCT06293989 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
NCT03920644 ·Status: UNKNOWN ·Phase: PHASE3
-
Diagnostic Work up and Management of Acute Onset Vertigo
NCT05062915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
NCT04219982 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
NCT01149369 ·Status: COMPLETED ·Phase: PHASE2
-
The Prevention and Treatment of Nausea Associated With Motion Sickness
NCT03986905 ·Status: COMPLETED ·Phase: PHASE3
-
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT03772340 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
NCT02500732 ·Status: COMPLETED ·Phase: PHASE2
-
Nebulizer Delivery of Intranasal Scopolamine
NCT04999449 ·Status: COMPLETED ·Phase: PHASE1
-
Sodium Bicarbonate for Acute Peripheral Vertigo
NCT05676216 ·Status: UNKNOWN ·Phase: NA
-
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT04327661 ·Status: COMPLETED ·Phase: PHASE3
-
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT05903924 ·Status: COMPLETED ·Phase: PHASE3
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
NCT01556932 ·Status: COMPLETED ·Phase: NA
-
A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness
NCT01198106 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
NCT05221892 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
NCT02970968 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Promethazine for Treatment of Diabetic Gastroparesis
NCT02130622 ·Status: TERMINATED ·Phase: PHASE2